Fludarabine Phosphate

WITHDRAWN · PHASE1 · Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma

Study withdrawn before opening to accrual.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.